YOU SEARCHED BY...
- Contract Services Directory
- Automated Pharmacology
- Accelerated Stability Studies
- Informatics
- Packaging, Liquids
- Packaging, Blister
- Manufacturing, Creams & Ointments
- IT, LIMS
- RNAi Technology
- HPLC
- Supply Chain Management
- Manufacturing, Clinical Trials Supply
- Drug Delivery Systems
- Clinical Trials Management
- Custom Synthesis
- training
Contract Service Directory
AstraCrux
Company Headquarters
3F, No.95, Guangfu North Road
Songshan District
Taipei, 105
Taiwan
Contract Service Directory
Related Content
-
Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
-
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Asahi Kasei Pharma Contracts ProBioGen
Will use ProBioGen’s technologies for the advancement of its biologics pipeline.Contract Pharma Staff 11.18.20
-
A Potential “Marriage”
Initiator companies and generics/CMOs working together.Emil W. Ciurczak, DoraMaxx Consulting 11.17.20
-
Information Technology | Supply Chain
The Pandemic & The Pharma Industry: 3 Things to Know
The importance of vendor contract visibility, an increase in intense legal scrutiny, and new technology for greater agility and control.Colin Earl, CTO at Agiloft 11.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.10.20.20
-
The Pandemic’s Become an Insurmountable Opportunity
Every Cloud has a Silver Lining(?)Emil W. Ciurczak, Contributing Editor 10.14.20
-
Breaking News | Collaborations & Alliances | CRO News
BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services
Will support new medical countermeasure research in the fight against emerging infectious disease.Contract Pharma Staff 10.08.20
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Metrics Contract Services Begins $10M Plant Expansion
Adds 3,760 square feet of production space to the current facility, providing added flexibility and capacity to the CDMO.Contract Pharma Staff 09.22.20
-
Breaking News | Facilities | Industry News
CoreRx Fully Operational in New Product Development Center
Expansion gives CoreRx’s clients access to over 150,000 sq. ft. of space at the ICOT center campus.Contract Pharma Staff 08.10.20
-
APIs | cGMP Manufacture | Clinical Trials | Supply Chain
Evaluating Pharma Amid COVID-19
Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformationKristin Brooks, Contract Pharma 05.18.20
-
cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
-
Clinical Trials | CRO News | Drug Development | Information Technology | R&D
CRO Industry Update
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.Kristin Brooks, Contract Pharma 04.27.20
